MedPath

UNIVERSITY OF WATERLOO

🇺🇸United States
Ownership
-
Established
1956-01-01
Employees
-
Market Cap
-
Website
https://uwaterloo.ca/

Advances in HIV Treatment: From Novel Prevention to Potential Cures

• A novel nanomedicine using siRNAs targeting CCR5 and Nef shows promise in preventing HIV sexual transmission by blocking viral entry and reactivating autophagy. • An HIV-virus-like particle (HLP) therapeutic can reactivate dormant HIV in immune cells, making them susceptible to cART and the immune system, potentially curing HIV. • Despite advancements, challenges remain in HIV management, including global disparities in treatment access, drug resistance, and the virus's ability to establish latent reservoirs.
© Copyright 2025. All Rights Reserved by MedPath